T 0207/94 (Human beta-interferon) of 08.04.1997
- European Case Law Identifier
- ECLI:EP:BA:1997:T020794.19970408
- Date of decision
- 8 April 1997
- Case number
- T 0207/94
- Petition for review of
- -
- Application number
- 81301414.9
- IPC class
- C12N 15/22
- Language of proceedings
- English
- Distribution
- Published in the EPO's Official Journal (A)
- Download
- Decision in English
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Séquences d'ADN, molécules d'ADN recombinant et procédé pour la production de l'interféron de fibroblaste humain(16.01.90)
- Applicant name
- Biogen, Inc.
- Opponent name
- Schering AG
- Board
- 3.3.04
- Headnote
In case the expression of a cloned DNA in a chosen foreign host constitutes the subject-matter of the claimed invention, reasonable expectation of success may be evaluated only by taking into account real difficulties related to that step. Hence, in order to be considered, any allegation of features putting in jeopardy reasonable expectation of success must be based upon technical facts.
- Relevant legal provisions
- European Patent Convention Art 54 1973European Patent Convention Art 56 1973European Patent Convention Art 87 1973European Patent Convention Art 88 1973
- Keywords
- Priority - (yes)
Novelty - (yes)
Inventive step - (no) - Catchword
- -
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.